维普中文期刊产品整合服务

Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury

查看全文 作  者:Chao-Chao [1,2]Qin;Yan-Ning [1,2]Liu;Ying [1,2]Hu;Ying [1,2]Yang;Zhi [1,2]Chen 高影响力作者 机构地区:[1]State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine;[2]Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases高影响力机构 出  处:《World Journal of Gastroenterology》索引2017年第23卷第17期,共10页高影响力期刊 基  金:Supported by the State 12th 5-Year Plan S&T Projects of China,No.2012ZX10002007;National Natural Science Foundation of China,No.81272679,No.81470851 摘  要:Macrophage inflammatory protein(MIP)-2 is one of the CXC chemokines and is also known as chemokine CXC ligand(CXCL2). MIP-2 affects neutrophil recruitment and activation through the p38 mitogen-activatedprotein-kinase-dependent signaling pathway, by binding to its specific receptors, CXCR1 and CXCR2. MIP-2 is produced by a variety of cell types, such as macrophages, monocytes, epithelial cells, and hepatocytes, in response to infection or injury. In liver injury, activated Kupffer cells are known as the major source of MIP-2. MIP-2-recruited and activated neutrophils can accelerate liver inflammation by releasing various inflammatory mediators. Here, we give a brief introduction to the basic molecular and cellular sources of MIP-2, and focus on its physiological and pathological functions in acute liver injury induced by concanavalin A, lipopolysaccharides, irradiation, ischemia/reperfusion, alcohol, and hypoxia, and hepatectomy-induced liver regeneration and tumor colorectal metastasis. Further understanding of the regulatory mechanisms of MIP-2 secretion and activation may be helpful to develop MIP-2-targeted therapeutic strategies to prevent liver inflammation. 关 键 词:巨噬细胞煽动性的 protein-2 肝损害 Polymorphonuclear neutrophils 巨噬细胞 发炎
相关文献

参考文献(107)

引证文献(26)

耦合文献(85)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费